文献速递其他结缔组织病

不同形式肌炎具有独特的细胞因子及细胞因子受体表达模式

Distinct cytokine and cytokine receptor expression patterns characterize different forms of myositis.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

对669例患者(含105例皮肌炎、80例免疫介导坏死性肌病、65例抗合成酶综合征、53例包涵体肌炎、19例抗PM/Scl肌炎、310例其他炎性或遗传性肌病及37例正常组织对照)的肌肉活检行批量RNA测序,分析338个编码细胞因子、细胞因子受体及免疫检查点基因的表达;包涵体肌炎患者差异过表达基因最多(71个),其中37个为包涵体肌炎特异性,并呈现强烈的1型炎症基因特征。

要点

  • 包涵体肌炎患者差异过表达基因最多(71个),其中37个为包涵体肌炎特异性。
  • 包涵体肌炎中高表达基因涉及1型炎症,包括CCL5、CXCR3、CCR5、CXCL9和IFNG。
  • 抗Jo1与抗PM/Scl患者过表达一组相似的基因,而皮肌炎患者过表达另一组涉及1型炎症的基因。

核心结论

  • 每个肌炎临床组和自身抗体亚组均有差异过表达的炎症介质,包括包涵体肌炎中强烈的1型炎症基因特征。

研究设计与样本

  • 对669例患者的肌肉活检样本行批量RNA测序,包括105例皮肌炎、80例免疫介导坏死性肌病、65例抗合成酶综合征、53例包涵体肌炎、19例抗PM/Scl肌炎、310例其他炎性或遗传性肌病和37例正常组织对照。
  • 分别分析肌炎临床组和自身抗体亚组,对338个编码细胞因子、细胞因子受体和免疫检查点的基因进行表达分析。
  • 通过寻找某一组与所有样本及与正常组织相比均特异性差异表达的基因(α<0.001)来确定肌炎组特异性基因。

主要发现

  • 包涵体肌炎患者在全部临床组中差异过表达基因最多(71个),其中37个为包涵体肌炎特异性。
  • 包涵体肌炎高表达基因中包括参与1型炎症的CCL5、CXCR3、CCR5、CXCL9和IFNG。
  • 抗Jo1和抗PM/Scl患者过表达一组相似的基因,而皮肌炎患者过表达另一组参与1型炎症的基因。
  • 免疫介导坏死性肌病患者差异过表达基因数量最少,无优势炎症模式。

关键数值与推荐

  • 肌炎组特异性基因的判定标准为:与所有样本相比及与正常组织相比均特异性差异表达,α<0.001。
  • 分析覆盖338个编码细胞因子、细胞因子受体和免疫检查点的基因。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Myositis is a heterogeneous family of inflammatory myopathies. We sought to define the differential expression of cytokines, cytokine receptors and immune checkpoint genes in muscle biopsies from patients with different forms of myositis in order to characterize patterns of inflammation in each. METHODS: Bulk RNA-sequencing was performed on muscle biopsy samples from 669 patients, including 105 with DM, 80 with immune-mediated necrotizing myopathy (IMNM), 65 with anti-synthetase syndrome, 53 with IBM, 19 with anti-PM/Scl myositis, 310 with other inflammatory or genetic myopathies and 37 controls with normal tissue (NT). Myositis clinical groups and autoantibody subgroups were analysed separately. Expression data were analysed for 338 genes encoding cytokines, cytokine receptors and immune checkpoints. Myositis group-specific genes were identified from this list by finding genes that were specifically differentially expressed in one group compared with all samples and compared with NT (α < 0.001). RESULTS: IBM patients had the most differentially overexpressed genes (71) among all clinical groups, including 37 that were IBM-specific. Among the top genes were several involved in type 1 inflammation, including CCL5, CXCR3, CCR5, CXCL9 and IFNG. Anti-Jo1 and anti-PM/Scl patients exhibited differential overexpression of a similar set of genes, while DM patients exhibited differential overexpression of a different set of genes involved in type 1 inflammation. IMNM patients had the least number of differentially overexpressed genes with no predominant inflammatory pattern. CONCLUSION: Each myositis clinical group and autoantibody subgroup had differentially overexpressed inflammatory mediators, including a strong type 1 inflammatory gene signature in IBM.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Kirou RA, Pinal-Fernandez I, Casal-Dominguez M, et al. Distinct cytokine and cytokine receptor expression patterns characterize different forms of myositis. Rheumatology (Oxford). 2025. PMID: 40579223. doi:10.1093/rheumatology/keaf346

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。